Inaktiver Wert

Algeta ASA Aktie Xetra

Aktien

Schlusskurs Xetra Andere Börsenplätze
- ^EUR	-

Actavis : Factbox - M&A frenzy transforming global pharma	06.05.14
Actavis : M&A frenzy in healthcare sector	06.05.14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24.03.14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24.02.14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19.12.13

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-1.61%	104 Mrd.
REGENERON PHARMACEUTICALS, INC.	+6.82%	97.47 Mrd.
ARGENX SE	+5.71%	22.25 Mrd.
BIONTECH SE	-12.70%	21.68 Mrd.
GENMAB A/S	-9.70%	18.2 Mrd.
WUXI APPTEC CO., LTD.	-39.98%	17.02 Mrd.
BEIGENE, LTD.	-10.32%	16.36 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+7.29%	14.39 Mrd.
SAREPTA THERAPEUTICS, INC.	+37.72%	12.37 Mrd.